SYNAPSE-ICU研究:急性脑损伤患者颅内压监测的国际前瞻性队列研究
该研究在42个国家146个ICU前瞻性纳入2395例急性脑损伤患者,评估颅内压监测的实践差异及其与6个月结局的关联。
核心结论
- 颅内压监测的使用和颅内压管理在不同中心和国家间差异很大。
- 颅内压监测可能与更积极的治疗措施相关,并在更严重病例中与更低的6个月死亡率相关。
- 对严重病例可考虑以监测指导的颅内高压治疗,因其可能与长期临床结局改善相关。
研究设计与样本
- 前瞻性观察性队列研究,在42个国家146个ICU进行。
- 纳入年龄≥18岁、因原发性出血性卒中或创伤性硬膜下/蛛网膜下腔出血或创伤性脑损伤入ICU,且入ICU时或脑损伤后48小时内GCS眼反应评分1分且运动反应评分≥5分的患者。
- 共评估4776例患者,最终纳入2395例,其中创伤性脑损伤1287例(54%)、颅内出血587例(25%)、蛛网膜下腔出血521例(22%)。
- 中位年龄55岁(IQR 39-69),男性1567例(65%)。
- 使用倾向评分逆概率治疗加权法评估颅内压监测与6个月结局的关联。
临床怎么用
- 在严重急性脑损伤病例中,可考虑使用颅内压监测指导颅内高压治疗。
- 对至少一个瞳孔无反应的患者,颅内压监测可能带来更低的6个月死亡率和更好的神经结局。
- 颅内压监测的使用应结合患者严重程度和中心实践,注意中心间差异较大。
局限性
- 为观察性研究,尽管使用倾向评分加权,仍可能存在未测量混杂。
- 研究结果可能受各中心治疗习惯和病例组合差异影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The indications for intracranial pressure (ICP) monitoring in patients with acute brain injury and the effects of ICP on patients' outcomes are uncertain. The aims of this study were to describe current ICP monitoring practises for patients with acute brain injury at centres around the world and to assess variations in indications for ICP monitoring and interventions, and their association with long-term patient outcomes. METHODS: We did a prospective, observational cohort study at 146 intensive care units (ICUs) in 42 countries. We assessed for eligibility all patients aged 18 years or older who were admitted to the ICU with either acute brain injury due to primary haemorrhagic stroke (including intracranial haemorrhage or subarachnoid haemorrhage) or traumatic brain injury. We included patients with altered levels of consciousness at ICU admission or within the first 48 h after the brain injury, as defined by the Glasgow Coma Scale (GCS) eye response score of 1 (no eye opening) and a GCS motor response score of at least 5 (not obeying commands). Patients not admitted to the ICU or with other forms of acute brain injury were excluded from the study. Between-centre differences in use of ICP monitoring were quantified by using the median odds ratio (MOR). We used the therapy intensity level (TIL) to quantify practice variations in ICP interventions. Primary endpoints were 6 month mortality and 6 month Glasgow Outcome Scale Extended (GOSE) score. A propensity score method with inverse probability of treatment weighting was used to estimate the association between use of ICP monitoring and these 6 month outcomes, independently of measured baseline covariates. This study is registered with ClinicalTrial.gov, NCT03257904. FINDINGS: Between March 15, 2018, and April 30, 2019, 4776 patients were assessed for eligibility and 2395 patients were included in the study, including 1287 (54%) with traumatic brain injury, 587 (25%) with intracranial haemorrhage, and 521 (22%) with subarachnoid haemorrhage. The median age of patients was 55 years (IQR 39-69) and 1567 (65%) patients were male. Considerable variability was recorded in the use of ICP monitoring across centres (MOR 4·5, 95% CI 3·8-4·9 between two randomly selected centres for patients with similar covariates). 6 month mortality was lower in patients who had ICP monitoring (441/1318 [34%]) than in those who were not monitored (517/1049 [49%]; p<0·0001). ICP monitoring was associated with significantly lower 6 month mortality in patients with at least one unreactive pupil (hazard ratio [HR] 0·35, 95% CI 0·26-0·47; p<0·0001), and better neurological outcome at 6 months (odds ratio 0·38, 95% CI 0·26-0·56; p=0·0025). Median TIL was higher in patients with ICP monitoring (9 [IQR 7-12]) than in those who were not monitored (5 [3-8]; p<0·0001) and an increment of one point in TIL was associated with a reduction in mortality (HR 0·94, 95% CI 0·91-0·98; p=0·0011). INTERPRETATION: The use of ICP monitoring and ICP management varies greatly across centres and countries. The use of ICP monitoring might be associated with a more intensive therapeutic approach and with lower 6-month mortality in more severe cases. Intracranial hypertension treatment guided by monitoring might be considered in severe cases due to the potential associated improvement in long-term clinical results. FUNDING: University of Milano-Bicocca and the European Society of Intensive Care Medicine.
引用
- Robba C, Graziano F, Rebora P, et al. Intracranial pressure monitoring in patients with acute brain injury in the intensive care unit (SYNAPSE-ICU): an international, prospective observational cohort study. Lancet Neurol. 2021. PMID: 34146513. doi:10.1016/S1474-4422(21)00138-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。